Physician profile
Jennifer A Freese
NPI 1346353489
$19,192.77
in general payments reported to CMS, 2019-2025
8 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $12.81 · 2021: $42.79 · 2022: $459 · 2023: $1,070 · 2024: $3,403 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $4,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,636.76 |
| Food and Beverage | $4,312.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $17,123.98 | 2022-2025 | Xeomin |
| Abbvie INC. | $973.57 | 2023-2025 | |
| Allergan, INC. | $589.04 | 2019-2022 | |
| Galderma Laboratories, L.P. | $135.48 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.49 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.00 | 2019 | |
| Lilly USA, LLC | $52.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Freese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.